Cargando…
Long COVID-19 Pathophysiology: What Do We Know So Far?
Long COVID-19 is a recognized entity that affects millions of people worldwide. Its broad clinical symptoms include thrombotic events, brain fog, myocarditis, shortness of breath, fatigue, muscle pains, and others. Due to the binding of the virus with ACE-2 receptors, expressed in many organs, it ca...
Autores principales: | Tziolos, Nikolaos-Renatos, Ioannou, Petros, Baliou, Stella, Kofteridis, Diamantis P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10609046/ https://www.ncbi.nlm.nih.gov/pubmed/37894116 http://dx.doi.org/10.3390/microorganisms11102458 |
Ejemplares similares
-
Amyloidogenesis: What Do We Know So Far?
por: Alraawi, Zeina, et al.
Publicado: (2022) -
What we know so far
Publicado: (2021) -
Antimicrobial Peptides in Infectious Diseases and Beyond—A Narrative Review
por: Ioannou, Petros, et al.
Publicado: (2023) -
Neuroproteomics in Epilepsy: What Do We Know so Far?
por: do Canto, Amanda M., et al.
Publicado: (2021) -
Eosinophilic Esophagitis—What Do We Know So Far?
por: Wąsik, Jakub, et al.
Publicado: (2023)